These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2900763)

  • 1. Bordetella pertussis adenylate cyclase. Penetration into host cells.
    Gentile F; Raptis A; Knipling LG; Wolff J
    Eur J Biochem; 1988 Aug; 175(3):447-53. PubMed ID: 2900763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration.
    Hanski E; Farfel Z
    J Biol Chem; 1985 May; 260(9):5526-32. PubMed ID: 2859287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin inhibits entry of Bordetella pertussis adenylate cyclase into animal cells.
    Shattuck RL; Storm DR
    Biochemistry; 1985 Nov; 24(23):6323-8. PubMed ID: 2867777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive adenylate cyclase toxin of Bordetella pertussis.
    Hanski E
    Trends Biochem Sci; 1989 Nov; 14(11):459-63. PubMed ID: 2560273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin.
    Gordon VM; Leppla SH; Hewlett EL
    Infect Immun; 1988 May; 56(5):1066-9. PubMed ID: 2895741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.
    Mouallem M; Farfel Z; Hanski E
    Infect Immun; 1990 Nov; 58(11):3759-64. PubMed ID: 2172167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells.
    Gordon VM; Young WW; Lechler SM; Gray MC; Leppla SH; Hewlett EL
    J Biol Chem; 1989 Sep; 264(25):14792-6. PubMed ID: 2504710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adenylate cyclase toxin from Bordetella pertussis on human neutrophil interactions with Coccidioides immitis and Staphylococcus aureus.
    Galgiani JN; Hewlett EL; Friedman RL
    Infect Immun; 1988 Apr; 56(4):751-5. PubMed ID: 2894360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of catalytic and invasive activities of Bordetella pertussis adenylate cyclase.
    Raptis A; Knipling L; Wolff J
    Infect Immun; 1989 Jun; 57(6):1725-30. PubMed ID: 2542162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase.
    Murayama T; Hewlett EL; Maloney NJ; Justice JM; Moss J
    Biochemistry; 1994 Dec; 33(51):15293-7. PubMed ID: 7803392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin.
    Pearson RD; Symes P; Conboy M; Weiss AA; Hewlett EL
    J Immunol; 1987 Oct; 139(8):2749-54. PubMed ID: 2888823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin.
    Iwaki M; Kamachi K; Heveker N; Konda T
    Infect Immun; 1999 Jun; 67(6):2763-8. PubMed ID: 10338478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the bacterial cell associated calmodulin-sensitive adenylate cyclase from Bordetella pertussis.
    Masure HR; Storm DR
    Biochemistry; 1989 Jan; 28(2):438-42. PubMed ID: 2540797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular cAMP formation from host cell ATP by Bordetella pertussis adenylate cyclase.
    Gentile F; Raptis A; Knipling LG; Wolff J
    Biochim Biophys Acta; 1988 Aug; 971(1):63-71. PubMed ID: 2900655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a calmodulin-sensitive adenylate cyclase from Bordetella pertussis.
    Shattuck RL; Oldenburg DJ; Storm DR
    Biochemistry; 1985 Nov; 24(23):6356-62. PubMed ID: 2867778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC.
    Hewlett EL; Gray MC; Ehrmann IE; Maloney NJ; Otero AS; Gray L; Allietta M; Szabo G; Weiss AA; Barry EM
    J Biol Chem; 1993 Apr; 268(11):7842-8. PubMed ID: 8385122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mutant Bordetella pertussis adenylate cyclase toxins with reduced affinity for calmodulin. Implications for the mechanism of toxin entry into target cells.
    Heveker N; Ladant D
    Eur J Biochem; 1997 Feb; 243(3):643-9. PubMed ID: 9057827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis.
    Rogel A; Meller R; Hanski E
    J Biol Chem; 1991 Feb; 266(5):3154-61. PubMed ID: 1847141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of Ca2+ with the calmodulin-sensitive adenylate cyclase from Bordetella pertussis.
    Masure HR; Oldenburg DJ; Donovan MG; Shattuck RL; Storm DR
    J Biol Chem; 1988 May; 263(14):6933-40. PubMed ID: 2896201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive adenylyl cyclase of Bordetella pertussis. Physical, catalytic, and toxic properties.
    Gentile F; Knipling LG; Sackett DL; Wolff J
    J Biol Chem; 1990 Jun; 265(18):10686-92. PubMed ID: 1693922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.